Modern Medicine and the 20th Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs
AbstractThis paper studies the contribution of sulfa drugs, a groundbreaking medical innovation in the 1930s, to declines in U.S. mortality. For several often-fatal infectious diseases, sulfa drugs represented the first effective treatment. Using time-series and difference-in-differences methods (with diseases unaffected by sulfa drugs as a comparison group), we find that sulfa drugs led to a 25 to 40 percent decline in maternal mortality, 17 to 36 percent decline in pneumonia mortality, and 52 to 67 percent decline in scarlet-fever mortality between 1937 and 1943. Altogether, they reduced mortality by 2 to 4 percent and increased life expectancy by 0.4 to 0.8 years. We also find that sulfa drugs benefited whites more than blacks.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by National Bureau of Economic Research, Inc in its series NBER Working Papers with number 15089.
Date of creation: Jun 2009
Date of revision:
Publication status: published as “Modern Medicine and the 20th-Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs,” (with A. Lleras-Muney and K. Smith), American Economic Journal: Applied Economics, 2(2), April 2010, pp. 118-146
Note: DAE HC HE
Contact details of provider:
Postal: National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.
Web page: http://www.nber.org
More information through EDIRC
Find related papers by JEL classification:
- I10 - Health, Education, and Welfare - - Health - - - General
- J11 - Labor and Demographic Economics - - Demographic Economics - - - Demographic Trends, Macroeconomic Effects, and Forecasts
- N32 - Economic History - - Labor and Consumers, Demography, Education, Health, Welfare, Income, Wealth, Religion, and Philanthropy - - - U.S.; Canada: 1913-
This paper has been announced in the following NEP Reports:
- NEP-ALL-2009-07-03 (All new papers)
- NEP-HEA-2009-07-03 (Health Economics)
- NEP-HIS-2009-07-03 (Business, Economic & Financial History)
You can help add them by filling out this form.
CitEc Project, subscribe to its RSS feed for this item.
- Esther Duflo, 2011.
"Women’s Empowerment and Economic Development,"
NBER Working Papers
17702, National Bureau of Economic Research, Inc.
- repec:hka:wpaper:2013-05 is not listed on IDEAS
- Bhalotra, Sonia & Venkataramani, Atheendar, 2011. "Is The Captain of the Men of Death Still At Play? Long-Run Impacts of Early Life Pneumonia Exposure during Sulfa Drug Revolution in America," Proceedings of the German Development Economics Conference, Berlin 2011 10, Verein für Socialpolitik, Research Committee Development Economics.
- Sonia Bhalotra & Atheendar Venkataramani, 2011.
"The Captain of the Men of Death and His Shadow: Long-Run Impacts of Early Life Pneumonia Exposure,"
The Centre for Market and Public Organisation
11/273, Department of Economics, University of Bristol, UK.
- Sonia Bhalotra & Atheendar Venkataramani, 2011. "The Captain of the Men of Death and His Shadow: Long-Run Impacts of Early Life Pneumonia Exposure," CHILD Working Papers wp20_11, CHILD - Centre for Household, Income, Labour and Demographic economics - ITALY.
- Bhalotra, Sonia R. & Venkataramani, Atheendar, 2011. "The Captain of the Men of Death and His Shadow: Long-Run Impacts of Early Life Pneumonia Exposure," IZA Discussion Papers 6041, Institute for the Study of Labor (IZA).
- Stefania Albanesi, 2013. "Maternal Health and Fertility: An International Perspective," Working Papers 2013-005, Human Capital and Economic Opportunity Working Group.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ().
If references are entirely missing, you can add them using this form.